Abstract:Objective To explore the changes in plasma metabolite levels in patients with colorectal cancer (CRC) and to screen for potential tumor biomarkers.?Methods?Blood samples of 166 patients admitted to the Department of General Surgery of the First Affiliated Hospital of Jinzhou Medical University from September 2018 to August 2019 were selected and divided into the experimental group (120 cases) and the control group (46 cases). Liquid chromatography-tandem mass spectrometry (LC-MS / MS) was used to detect 23 amino acids and 26 acylcarnitines in plasma, and the differences in changes before and after surgery were compared among CRC patients and normal controls as well as CRC patients with different tumor stages.?Results?Alanine (Ala), arginine (Arg), citrulline (Cit), glutamine (Gln), methionine (Met), ornithine (Orn), proline (Pro), threonine (Thr), tyrosine (Tvr), succinylcarnitine (C4DC), decanoylcarnitine (C10), and tetracosanoylcarnitine (C24) in the plasma of the experimental group were all higher than those in the control group (P < 0.05). There was a statistically significant difference in C4DC in plasma of patients with stage Ⅰ, Ⅱ, Ⅲ and Ⅳ of CRC (P < 0.05). The levels of Ala, Cit, Gln, Pro, C10, and C24 were lower than those before surgery (P < 0.05), while the levels of Orn and Thr were higher than those before surgery (P < 0.05).?Conclusions?Plasma metabolites such as Ala, Cit, Orn, Pro, C4DC, and C10 in colorectal cancer patients are of important significance in the diagnosis of colorectal cancer.